Parties Dispute Validity Of Sloan-Kettering Immunotherapy Patent
WASHINGTON, D.C. — In a Dec. 15 response brief, a patent challenger tells the Federal Circuit U.S. Court of Appeals that the Patent Trial and Appeal Board erred in finding no...To view the full article, register now.
Already a subscriber? Click here to view full article